Published in Clin Pharmacol Ther on August 01, 1995
Ketamine and Changes of the Short Portable Mental Status Questionnaire (SPMSQ-E) | NCT02049411
A key role of the basal ganglia in pain and analgesia--insights gained through human functional imaging. Mol Pain (2010) 1.26
Thinking glutamatergically: changing concepts of schizophrenia based upon changing neurochemical models. Clin Schizophr Relat Psychoses (2010) 1.06
The central nervous system effects, pharmacokinetics and safety of the NAALADase-inhibitor GPI 5693. Br J Clin Pharmacol (2005) 1.06
Glycine transport inhibitors for the treatment of schizophrenia. Open Med Chem J (2010) 1.00
Assessment of the effect of dextromethorphan and ketamine on the acute nociceptive threshold and wind-up of the second pain response in healthy male volunteers. Br J Clin Pharmacol (2002) 0.86
Metaplastic effects of subanesthetic ketamine on CA1 hippocampal function. Neuropharmacology (2014) 0.81
Sleep-dependent declarative memory consolidation--unaffected after blocking NMDA or AMPA receptors but enhanced by NMDA coagonist D-cycloserine. Neuropsychopharmacology (2013) 0.80
Acute S-ketamine application does not alter cerebral [18F]altanserin binding: a pilot PET study in humans. J Neural Transm (Vienna) (2007) 0.80
Application of cross-species PET imaging to assess neurotransmitter release in brain. Psychopharmacology (Berl) (2015) 0.79
Treatment-Resistant Major Depression: Rationale for NMDA Receptors as Targets and Nitrous Oxide as Therapy. Front Psychiatry (2015) 0.77
Ninety-six hour ketamine infusion with co-administered clonidine for treatment-resistant depression: A pilot randomised controlled trial. World J Biol Psychiatry (2016) 0.76
Ketamine: NMDA Receptors and Beyond. J Neurosci (2016) 0.75
A subanesthetic dose of ketamine in the Rhesus monkey reduces the occurrence of anticipatory saccades. Psychopharmacology (Berl) (2015) 0.75
Cloning and sequencing of the pertussis toxin genes: operon structure and gene duplication. Proc Natl Acad Sci U S A (1986) 5.59
End-of-life decisions in neonatal intensive care: physicians' self-reported practices in seven European countries. EURONIC Study Group. Lancet (2000) 4.01
Parental visiting, communication, and participation in ethical decisions: a comparison of neonatal unit policies in Europe. Arch Dis Child Fetal Neonatal Ed (1999) 3.14
Disposition of chloroquine in man after single intravenous and oral doses. Br J Clin Pharmacol (1983) 2.59
Should euthanasia be legal? An international survey of neonatal intensive care units staff. Arch Dis Child Fetal Neonatal Ed (2004) 2.21
The effect of epinephrine on adenosine 3', 5'-phosphate levels in the isolated perfused rat heart. Mol Pharmacol (1965) 2.20
Treatment choices for extremely preterm infants: an international perspective. J Pediatr (2000) 2.19
Determination of morphine, morphine-3-glucuronide and (tentatively) morphine-6-glucuronide in plasma and urine using ion-pair high-performance liquid chromatography. J Chromatogr (1982) 2.07
Reporting of data from out-of-hospital cardiac arrest has to involve emergency medical dispatching--taking the recommendations on reporting OHCA the Utstein style a step further. Resuscitation (2011) 1.84
Adverse effects of extradural and intrathecal opiates: report of a nationwide survey in Sweden. Br J Anaesth (1982) 1.77
Neurochemical monitoring using intracerebral microdialysis in patients with subarachnoid hemorrhage. J Neurosurg (1996) 1.75
Evaluation of the quality of amodiaquine and sulphadoxine/pyrimethamine tablets sold by private wholesale pharmacies in Dar Es Salaam Tanzania. J Clin Pharm Ther (2003) 1.71
The incidence of chronic post-sternotomy pain after cardiac surgery--a prospective study. Acta Anaesthesiol Scand (2001) 1.69
Assessing health worker performance in malaria case management of underfives at health facilities in a rural Tanzanian district. Trop Med Int Health (2007) 1.64
Pentamidine concentrations in plasma, whole blood and cerebrospinal fluid during treatment of Trypanosoma gambiense infection in Côte d'Ivoire. Trans R Soc Trop Med Hyg (1992) 1.63
Diagnostic utility of flumazenil in coma with suspected poisoning: a double blind, randomised controlled study. BMJ (1990) 1.62
The effect of epinephrine and other agents on adenyl cyclase in the cell membrane of avian erythrocytes. Biochim Biophys Acta (1966) 1.52
Colonic ischaemia and intra-abdominal hypertension following open repair of ruptured abdominal aortic aneurysm. Br J Surg (2009) 1.51
Differential psychopathology and patterns of cerebral glucose utilisation produced by (S)- and (R)-ketamine in healthy volunteers using positron emission tomography (PET). Eur Neuropsychopharmacol (1997) 1.49
Neonatal end-of-life decision making: Physicians' attitudes and relationship with self-reported practices in 10 European countries. JAMA (2000) 1.49
Can villous atrophy be induced by chronic alcohol consumption? J Intern Med (1989) 1.41
Personalizing healthcare: from genetics through payment to improving care? J R Soc Med (2013) 1.40
The analgesic effect of racemic ketamine in patients with chronic ischemic pain due to lower extremity arteriosclerosis obliterans. Acta Anaesthesiol Scand (1998) 1.40
Laboratory determination of chemotherapeutic drug resistance in tumor cells from patients with leukemia, using a fluorometric microculture cytotoxicity assay (FMCA). Int J Cancer (1992) 1.37
On the question of dose-dependent chloroquine elimination of a single oral dose. Clin Pharmacol Ther (1983) 1.34
Spin torque-generated magnetic droplet solitons. Science (2013) 1.33
Morphine metabolism in cancer patients on increasing oral doses--no evidence for autoinduction or dose-dependence. Br J Clin Pharmacol (1983) 1.33
A short synthetic peptide fragment of human interleukin 1 with immunostimulatory but not inflammatory activity. J Immunol (1986) 1.30
The lectin-like domain of thrombomodulin interferes with complement activation and protects against arthritis. J Thromb Haemost (2006) 1.28
Estimation of biomass in growing cell lines by adenosine triphosphate assay. Methods Enzymol (1986) 1.27
Dynamics of re-expansion of atelectasis during general anaesthesia. Br J Anaesth (1999) 1.24
Characterization of chloroquine plasma protein binding in man. Br J Clin Pharmacol (1983) 1.21
Interstitial glycerol as a marker for membrane phospholipid degradation in the acutely injured human brain. J Neurol Neurosurg Psychiatry (1998) 1.21
Synthesis of L- and D-[methyl-11C]methionine. J Nucl Med (1987) 1.20
Effects of (S)-ketamine on striatal dopamine: a [11C]raclopride PET study of a model psychosis in humans. J Psychiatr Res (2000) 1.19
Simultaneous intracerebral microdialysis and positron emission tomography in the detection of ischemia in patients with subarachnoid hemorrhage. J Cereb Blood Flow Metab (1996) 1.18
In vivo immunostimulating activity of the 163-171 peptide of human IL-1 beta. J Immunol (1987) 1.16
Recommended guidelines for reporting on emergency medical dispatch when conducting research in emergency medicine: the Utstein style. Resuscitation (2008) 1.13
Failure of pivampicillin in treating chlamydial infections. Br J Vener Dis (1984) 1.13
Bantu Tanzanians have a decreased capacity to metabolize omeprazole and mephenytoin in relation to their CYP2C19 genotype. Clin Pharmacol Ther (1998) 1.12
Codeine O-demethylation co-segregates with polymorphic debrisoquine hydroxylation. Br J Clin Pharmacol (1989) 1.12
Present state of extradural and intrathecal opioid analgesia in Sweden. A nationwide follow-up survey. Br J Anaesth (1987) 1.11
Interindividual and interethnic differences in the demethylation and glucuronidation of codeine. Br J Clin Pharmacol (1989) 1.11
The metabolism and bioavailability of morphine in patients with severe liver cirrhosis. Br J Clin Pharmacol (1990) 1.11
Pharmacokinetics of codeine and its metabolites in Caucasian healthy volunteers: comparisons between extensive and poor hydroxylators of debrisoquine. Br J Clin Pharmacol (1991) 1.10
Development and use of fluorescent nanosensors for metabolite imaging in living cells. Biochem Soc Trans (2005) 1.10
Interaction of the chiral forms of ketamine with opioid, phencyclidine, sigma and muscarinic receptors. Pharmacol Toxicol (1995) 1.10
Middle cerebral artery occlusion and reperfusion in primates monitored by microdialysis and sequential positron emission tomography. Stroke (2001) 1.10
Binding of human C4BP to the hypervariable region of M protein: a molecular mechanism of phagocytosis resistance in Streptococcus pyogenes. Mol Microbiol (2001) 1.09
A new version of the ischemic tourniquet pain test. Methods Find Exp Clin Pharmacol (1991) 1.07
Relationship between cyclic AMP metabolism and inotropic response of perfused rat hearts to phenylephrine and other adrenergic amines. Adv Cyclic Nucleotide Res (1975) 1.06
Streptococcal M protein: structural studies of the hypervariable region, free and bound to human C4BP. Biochemistry (2006) 1.06
CYP3A5 genotype has an impact on the metabolism of the HIV protease inhibitor saquinavir. Clin Pharmacol Ther (2007) 1.05
Chloroquine and desethylchloroquine in plasma, serum, and whole blood: problems in assay and handling of samples. Ther Drug Monit (1985) 1.05
Isolated hypervariable regions derived from streptococcal M proteins specifically bind human C4b-binding protein: implications for antigenic variation. J Immunol (2001) 1.05
Effects of dibenzepine and imipramine on the isolated rat heart. Eur J Pharmacol (1971) 1.04
Detection of tumor-specific cytotoxic drug activity in vitro using the fluorometric microculture cytotoxicity assay and primary cultures of tumor cells from patients. Int J Cancer (1994) 1.04
Clinical diagnosis of malaria and the risk of chloroquine self-medication in rural health centres in Burkina Faso. Trop Med Int Health (2008) 1.04
Gallstones, cholecystectomy, and duodenogastric reflux of bile acid. Scand J Gastroenterol (1986) 1.04
Clinical experience of long-term treatment with epidural and intrathecal opioids--a nationwide survey. Acta Anaesthesiol Scand (1988) 1.04
Positive end-expiratory pressure prevents atelectasis during general anaesthesia even in the presence of a high inspired oxygen concentration. Acta Anaesthesiol Scand (1999) 1.03
Indinavir-based treatment of HIV-1 infected patients: efficacy in the central nervous system. AIDS (1999) 1.03
High-performance liquid chromatographic method for determination of amodiaquine, chloroquine and their monodesethyl metabolites in biological samples. J Chromatogr B Analyt Technol Biomed Life Sci (2003) 1.03
A monoclonal antibody to the IL-1 beta peptide 163-171 blocks adjuvanticity but not pyrogenicity of IL-1 beta in vivo. J Immunol (1989) 1.02
Pharmacokinetics and red cell utilization of iron(III) hydroxide-sucrose complex in anaemic patients: a study using positron emission tomography. Br J Haematol (1999) 1.02
Work technique and its consequences for musculoskeletal disorders. Ergonomics (1987) 1.01
Large scale neurocognitive networks underlying episodic memory. J Cogn Neurosci (2000) 1.00
Disposition of fluvoxamine in humans is determined by the polymorphic CYP2D6 and also by the CYP1A2 activity. Clin Pharmacol Ther (1996) 1.00
Pseudohypoparathyroidism: a difficult diagnosis in early childhood. Acta Paediatr Scand (1976) 1.00
Effectiveness of a community intervention on malaria in rural Tanzania - a randomised controlled trial. Afr Health Sci (2010) 1.00
Limb salvage with isolated perfusion for soft tissue sarcoma: could less TNF-alpha be better? Ann Oncol (2005) 0.99
[Evans' syndrome: a retrospective study from the ship (French Society of Pediatric Hematology and Immunology) (36 cases)]. Arch Pediatr (2005) 0.99
Evaluation of three qualitative tests for detection of chloroquine in urine--agreement with plasma concentrations determined with liquid chromatography. Ann Trop Med Parasitol (1986) 0.98
Development of cyclic AMP metabolism in rat liver. A correlative study of tissue levels of cyclic AMP, accumulation of cyclic AMP in slices, adenylate cyclase activity and cyclic nucleotide phosphodiesterase activity. Biochim Biophys Acta (1973) 0.98
Reliability of Dill-Glazko test. Lancet (1985) 0.97
Prolonged analgesic effect of ketamine, an N-methyl-D-aspartate receptor inhibitor, in patients with chronic pain. J Pharmacol Exp Ther (1999) 0.97
Pharmacokinetics of quinine and its metabolites in pregnant Sudanese women with uncomplicated Plasmodium falciparum malaria. J Clin Pharm Ther (2007) 0.96
Phantom limb pain in the human brain: unraveling neural circuitries of phantom limb sensations using positron emission tomography. Ann Neurol (2000) 0.95
Continuous subcutaneous administration of the N-methyl-D-aspartic acid (NMDA) receptor antagonist ketamine in the treatment of post-herpetic neuralgia. Pain (1995) 0.95
Nonlinearity of amoxicillin absorption kinetics in human. Eur J Clin Pharmacol (1992) 0.95
Extremely rapid hydroxylation of debrisoquine: a case report with implication for treatment with nortriptyline and other tricyclic antidepressants. Ther Drug Monit (1985) 0.95
Synthesis of alpha beta-poly((2-hydroxyethyl)-DL-aspartamide), a new plasma expander. J Med Chem (1973) 0.94
Effect of ketamine, an NMDA receptor inhibitor, in acute and chronic orofacial pain. Pain (1995) 0.94
Changing pattern in aetiology of pancreatitis in an urban Swedish area. Br J Surg (1979) 0.94
HLA-DRB1*04 and DRB1*10 are associated with resistance and susceptibility, respectively, in Brazilian and Vietnamese leprosy patients. Genes Immun (2007) 0.94
A metabolic threshold of irreversible ischemia demonstrated by PET in a middle cerebral artery occlusion-reperfusion primate model. Acta Neurol Scand (2000) 0.94
Regional deposition of inhaled 11C-nicotine vapor in the human airway as visualized by positron emission tomography. Clin Pharmacol Ther (1995) 0.94
GLP-1 suppresses gastrointestinal motility and inhibits the migrating motor complex in healthy subjects and patients with irritable bowel syndrome. Neurogastroenterol Motil (2008) 0.93
CSF and plasma pharmacokinetics of the NMDA receptor antagonist CPP after intrathecal, extradural and i.v. administration in anaesthetized pigs. Br J Anaesth (1995) 0.93
Inhibition of cytochrome P4502D6 activity with paroxetine normalizes the ultrarapid metabolizer phenotype as measured by nortriptyline pharmacokinetics and the debrisoquin test. Clin Pharmacol Ther (2001) 0.93
The effect of leukotriene C4 and D4 on cutaneous blood flow in humans. Prostaglandins (1982) 0.93
Comparison of ketamine and pethidine in experimental and postoperative pain. Pain (1989) 0.92
A radioimmunoassay for cyclic AMP (cAMP) obtained by acetylation of both unlabeled and labeled (3H-cAMP) ligand, or of unlabeled ligand only. Acta Pharmacol Toxicol (Copenh) (1980) 0.91
The roles of cytochrome P450 3A4 and 1A2 in the 3-hydroxylation of quinine in vivo. Clin Pharmacol Ther (1999) 0.91
Skeletal metastases from breast cancer: uptake of 18F-fluoride measured with positron emission tomography in correlation with CT. Skeletal Radiol (1998) 0.91
Methadone, ciprofloxacin, and adverse drug reactions. Lancet (2000) 0.91
Decreased capacity for debrisoquine metabolism among black Tanzanians: analyses of the CYP2D6 genotype and phenotype. Pharmacogenetics (1999) 0.91